Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bevacizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Angiogenesis inhibitor |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Pegaptanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Vandetanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Lenalidomide (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Sorafenib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Ranibizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Pegaptanib sodium (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Axitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Sorafenib tosylate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Regorafenib |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Pomalidomide |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Aflibercept |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Sunitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|
Sunitinib malate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Angiogenesis inhibitor (disposition) |
Inferred relationship |
Some |
|